Management of deep vein thrombosis and pulmonary embolism. A statement for healthcare professionals. Council on Thrombosis (in consultation with the Council on Cardiovascular Radiology), American Heart Association.

Deep vein thrombosis (DVT) is a common but elusive illness that can result in suffering and death if not recognized and treated effectively. DVT occurs in ≈2 million Americans each year. Death can occur when the venous thrombi break off and form pulmonary emboli, which pass to and obstruct the arteries of the lungs. DVT and pulmonary embolism (PE) most often complicate the course of sick, hospitalized patients but may also affect ambulatory and otherwise healthy persons.1 2 3 4 It is estimated that each year 600 000 patients develop PE and that 60 000 die of this complication.5 6 7 This number exceeds the number of American women who die each year from breast cancer. PE is now the most frequent cause of death associated with childbirth.8 Women are a prime target for PE, being affected more often than men. Deep vein thrombosis is a major complication in orthopedic surgical patients and patients with cancer and other chronic illnesses. DVT can be a chronic disease. Patients who survive the initial episode of DVT are prone to chronic swelling of the leg and pain because the valves in the veins can be damaged by the thrombotic process, leading to venous hypertension. In some instances skin ulceration and impaired mobility prevent patients from leading normal, active lives. In addition, patients with DVT are prone to recurrent episodes. In those instances in which DVT and PE develop as complications of a surgical or medical illness, in addition to the mortality risk, hospitalization is prolonged and healthcare costs are increased. Over the past 20 years results of clinical trials have provided information that has revolutionized the approach to management of venous thromboembolic disease. New diagnostic modalities and therapeutic agents have been developed that are more effective, less expensive, and more …

[1]  P. Brill-Edwards,et al.  Antiphospholipid antibodies and venous thromboembolism. , 1995, Blood.

[2]  F. Violi,et al.  Thrombosis in the antiphospholipid-antibody syndrome. , 1995, The New England journal of medicine.

[3]  M. Gent,et al.  Optimal Duration of Oral Anticoagulant Therapy: A Randomized Trial Comparing Four Weeks with Three Months of Warfarin in Patients with Proximal Deep Vein Thrombosis , 1995, Thrombosis and Haemostasis.

[4]  Olle Linder,et al.  A Comparison of Six Weeks with Six Months of Oral Anticoagulant Therapy after a First Episode of Venous Thromboembolism , 1995 .

[5]  J. Hirsh The optimal duration of anticoagulant therapy for venous thrombosis. , 1995, The New England journal of medicine.

[6]  Paolo Prandoni,et al.  Accuracy of clinical assessment of deep-vein thrombosis , 1995, The Lancet.

[7]  J. Hirsh,et al.  Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. , 1995, The New England journal of medicine.

[8]  T. Barbui,et al.  Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosis. , 1995, The New England journal of medicine.

[9]  J. Douketis,et al.  A novel and rapid whole-blood assay for D-dimer in patients with clinically suspected deep vein thrombosis. , 1995, Circulation.

[10]  G. Hughes,et al.  The management of thrombosis in the antiphospholipid-antibody syndrome. , 1995, The New England journal of medicine.

[11]  J. Griffin,et al.  Use of a generally applicable tissue factor--dependent factor V assay to detect activated protein C-resistant factor Va in patients receiving warfarin and in patients with a lupus anticoagulant. , 1995, Blood.

[12]  G. Rodgers Activated protein C resistance and inherited thrombosis. , 1995, American journal of clinical pathology.

[13]  P. Pencharz,et al.  A cross-sectional study of catheter-related thrombosis in children receiving total parenteral nutrition at home. , 1995, The Journal of pediatrics.

[14]  K. Schulman,et al.  Cost-effectiveness analyses. , 1995, The New England journal of medicine.

[15]  G. Raskob,et al.  Hemorrhagic complications of anticoagulant treatment. , 1992, Chest.

[16]  R. White,et al.  Temporary Discontinuation of Warfarin Therapy: Changes in the International Normalized Ratio , 1995, Annals of Internal Medicine.

[17]  J. Hirsh,et al.  Accuracy of Ultrasound for the Diagnosis of Deep Venous Thrombosis in Asymptomatic Patients after Orthopedic Surgery , 1995, Annals of Internal Medicine.

[18]  J. Kelton,et al.  Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: an explanation for the thrombotic complications of heparin-induced thrombocytopenia. , 1994, Blood.

[19]  P. Reitsma,et al.  Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation , 1994, The Lancet.

[20]  J. Kelton,et al.  Immunoglobulin G from patients with heparin-induced thrombocytopenia binds to a complex of heparin and platelet factor 4. , 1994, Blood.

[21]  Pieter H. Reitsma,et al.  Mutation in blood coagulation factor V associated with resistance to activated protein C , 1994, Nature.

[22]  A. Greinacher,et al.  Heparin-Associated Thrombocytopenia: The Effects of Various Intravenous lgG Preparations on Antibody Mediated Platelet Activation - A Possible New Indication for High Dose i.v. IgG , 1994, Thrombosis and Haemostasis.

[23]  A. Greinacher,et al.  Laboratory diagnosis of heparin‐associated thrombocytopenia and comparison of platelet aggregation test, heparin‐induced platelet activation test, and platelet factor 4/heparin enzyme‐linked immunosorbent assay , 1994, Transfusion.

[24]  B. Chong,et al.  Plasma P-selectin is increased in thrombotic consumptive platelet disorders , 1994 .

[25]  M. Bernstein,et al.  Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE , 1994 .

[26]  B. Dahlbäck,et al.  Resistance to activated protein C as a basis for venous thrombosis. , 1994, The New England journal of medicine.

[27]  A. Greinacher,et al.  Heparin-associated thrombocytopenia: isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen. , 1994, Thrombosis and haemostasis.

[28]  F. R. Rosendaal,et al.  Thromboembolic and Bleeding Complications in Patients With Mechanical Heart Valve Prostheses , 1994, Circulation.

[29]  J. Hirsh,et al.  A randomized trial comparing activated thromboplastin time with heparin assay in patients with acute venous thromboembolism requiring large daily doses of heparin. , 1994, Archives of internal medicine.

[30]  M. Monreal,et al.  Comparison of Subcutaneous Unfractionated Heparin with a Low Molecular Weight Heparin (Fragmin®) in Patients with Venous Thromboembolism and Contraindications to Coumarin , 1994, Thrombosis and Haemostasis.

[31]  H. Bounameaux Low-molecular-weight heparins in prophylaxis and therapy of thromboembolic diseases , 1994 .

[32]  J. Scott,et al.  Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells. , 1994, The Journal of clinical investigation.

[33]  P. Ankola,et al.  Effect of Adding Heparin in Very Low Concentration to the Infusate to Prolong the Patency of Umbilical Artery Catheters , 1993, American journal of perinatology.

[34]  J. Hirsh,et al.  Distribution of thrombosis in patients with symptomatic deep vein thrombosis. Implications for simplifying the diagnostic process with compression ultrasound. , 1993, Archives of internal medicine.

[35]  F. Rosendaal,et al.  Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study , 1993, The Lancet.

[36]  B. O'brien,et al.  Efficacy and Cost of Low-Molecular-Weight Heparin Compared with Standard Heparin for the Prevention of Deep Vein Thrombosis after Total Hip Arthroplasty , 1993, Annals of Internal Medicine.

[37]  G. Raskob,et al.  A comparison of subcutaneous low-molecular-weight heparin with warfarin sodium for prophylaxis against deep-vein thrombosis after hip or knee implantation. , 1993, The New England journal of medicine.

[38]  J. Hirsh,et al.  Heparin Binding Proteins Contribution to Heparin Rebound After Cardiopulmonary Bypass , 1993, Circulation.

[39]  Robert Raschke,et al.  The Weight-based Heparin Dosing Nomogram Compared with a Standard Care Nomogram , 1993, Annals of Internal Medicine.

[40]  A. Zivelin,et al.  Mechanism of the anticoagulant effect of warfarin as evaluated in rabbits by selective depression of individual procoagulant vitamin K-dependent clotting factors. , 1993, The Journal of clinical investigation.

[41]  J. Hirsh,et al.  Comparison of the Non-Specific Binding of Unfractionated Heparin and Low Molecular Weight Heparin (Enoxaparin) to Plasma Proteins , 1993, Thrombosis and Haemostasis.

[42]  H. Magnani Heparin-Induced Thrombocytopenia (HIT): An Overview of 230 Patients Treated with Orgaran (Org 10172) , 1993, Thrombosis and Haemostasis.

[43]  J. Griffin,et al.  Anticoagulant protein C pathway defective in majority of thrombophilic patients. , 1993, Blood.

[44]  P Prandoni,et al.  A Simple Ultrasound Approach for Detection of Recurrent Proximal‐Vein Thrombosis , 1993, Circulation.

[45]  M. Andrew,et al.  Venous thromboembolic complications in children. , 1993, The Journal of pediatrics.

[46]  P. D. de Groot,et al.  Patients with antiphospholipid antibodies and venous thrombosis should receive long term anticoagulant treatment. , 1993, Annals of the rheumatic diseases.

[47]  A. Laupacis,et al.  A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement. , 1993, The New England journal of medicine.

[48]  J. Hirsh,et al.  Establishing a Therapeutic Range for Heparin Therapy , 1993, Annals of Internal Medicine.

[49]  J. Hirsh Low molecular weight heparin , 2007 .

[50]  B. Chong,et al.  The Clinical Usefulness of the Platelet Aggregation Test for the Diagnosis of Heparin-Induced Thrombocytopenia , 1993, Thrombosis and Haemostasis.

[51]  S. Hanson Evaluation of a new treatment strategy for Paget-Schroetter syndrome: Spontaneous thrombosis of the axillary-subclavian vein , 1993 .

[52]  B. Dahlbäck,et al.  Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[53]  H. Machleder Evaluation of a new treatment strategy for Paget-Schroetter syndrome: spontaneous thrombosis of the axillary-subclavian vein. , 1993, Journal of vascular surgery.

[54]  J. Hirsh,et al.  Limitations of Impedance Plethysmography in the Diagnosis of Clinically Suspected Deep-Vein Thrombosis , 1993, Annals of Internal Medicine.

[55]  C. Demers,et al.  Deep venous thrombosis and pulmonary embolism in pregnancy. , 1992, Clinics in chest medicine.

[56]  H R Büller,et al.  Acenocoumarol and heparin compared with acenocoumarol alone in the initial treatment of proximal-vein thrombosis. , 1992, The New England journal of medicine.

[57]  S M Nazarian,et al.  Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. , 1992, The New England journal of medicine.

[58]  J. Cronenwett,et al.  Current use of inferior vena cava filters. , 1992, Journal of vascular surgery.

[59]  M. Prins,et al.  Deep-vein thrombosis and the incidence of subsequent symptomatic cancer. , 1992, The New England journal of medicine.

[60]  Researchcommitteeofthebritish Optimum duration of anticoagulation for deep-vein thrombosis and pulmonary embolism*1 , 1992 .

[61]  J. Hirsh,et al.  Heparin: mechanism of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety. , 1992, Chest.

[62]  J. Amiral,et al.  Platelet Factor 4 Complexed to Heparin Is the Target for Antibodies Generated in Heparin-Induced Thrombocytopenia , 1992, Thrombosis and Haemostasis.

[63]  H. Büller,et al.  Clinical Utility of Real-Time Compression Ultrasonography for Diagnostic Management of Patients with Recurrent Venous Thrombosis , 1992, Acta radiologica.

[64]  M. Prins,et al.  Heparin Binding to Plasma Proteins, an Important Mechanism for Heparin Resistance , 1992, Thrombosis and Haemostasis.

[65]  R. Green,et al.  Pulmonary embolism in younger adults. , 1992, Chest.

[66]  P. Brill-Edwards,et al.  Venous Thrombosis during Pregnancy: Leg and Trimester of Presentation , 1992, Thrombosis and Haemostasis.

[67]  A. Greinacher,et al.  Heparin-Associated Thrombocytopenia: The Antibody Is Not Heparin Specific , 1992, Thrombosis and Haemostasis.

[68]  B. Alving,et al.  Pharmacology and mechanism of action of ancrod: potential for inducing thrombosis. , 1992, Blood.

[69]  T. Ahmed,et al.  Cure in acute promyelocytic leukemia: now more readily achievable with less toxic therapy. , 1992, Blood.

[70]  M. Levine,et al.  Thrombolytic therapy for the treatment of acute pulmonary embolism. , 1992, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[71]  David Hunt,et al.  ISIS-3 - A RANDOMIZED COMPARISON OF STREPTOKINASE VS TISSUE PLASMINOGEN-ACTIVATOR VS ANISTREPLASE AND OF ASPIRIN PLUS HEPARIN VS ASPIRIN ALONE AMONG 41,299 CASES OF SUSPECTED ACUTE MYOCARDIAL-INFARCTION , 1992 .

[72]  G. Leone,et al.  Hematological Causes of Venous Thrombosis in Young People: High Incidence of Myeloproliferative Disorder as Underlying Disease in Patients with Splanchnic Venous Thrombosis , 1992, Thrombosis and Haemostasis.

[73]  H. Büller,et al.  Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deep-vein thrombosis , 1992, The Lancet.

[74]  D. Hommes,et al.  Subcutaneous Heparin Compared with Continuous Intravenous Heparin Administration in the Initial Treatment of Deep Vein Thrombosis , 1992, Annals of Internal Medicine.

[75]  E. Stauffer,et al.  Color-flow duplex scanning for the surveillance and diagnosis of acute deep venous thrombosis. , 1992, Journal of vascular surgery.

[76]  A. Alavi,et al.  Complications and Validity of Pulmonary Angiography in Acute Pulmonary Embolism , 1992, Circulation.

[77]  J. T. ten Cate,et al.  Contrast Venography, the Gold Standard for the Diagnosis of Deep-Vein Thrombosis: lmprovement in Observer Agreement , 1992, Thrombosis and Haemostasis.

[78]  D. P. Bentley,et al.  Effective Reversal of Warfarin-lnduced Excessive Anticoagulation with Low Dose Mtamin K1 , 1992, Thrombosis and Haemostasis.

[79]  M. Gent,et al.  Antithrombotic therapy for cerebrovascular disorders. , 1989, Chest.

[80]  J. Hirsh,et al.  Rationale and results of thrombolytic therapy for deep-vein thrombosis , 1992 .

[81]  M. N. Silverstein Anagrelide, a therapy for thrombocythemic states: experience in 577 patients. Anagrelide Study Group. , 1992, The American journal of medicine.

[82]  E. Favaloro,et al.  Heparin ‐ Induced Thrombocytopenia: Laboratory Investigation and Confirmation Of Diagnosis , 1992, Pathology.

[83]  A. Greinacher,et al.  A Rapid and Sensitive Test for Diagnosing Heparin-Associated Thrombocytopenia , 1991, Thrombosis and Haemostasis.

[84]  P. Brill-Edwards,et al.  Rapid anticoagulation using ancrod for heparin-induced thrombocytopenia. , 1991, Blood.

[85]  J. Philbrick,et al.  Axillary and subclavian venous thrombosis. Prognosis and treatment. , 1991, Archives of internal medicine.

[86]  H. Büller,et al.  Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low molecular weight heparin. , 1991, BMJ.

[87]  J. Edney,et al.  Utility of duplex ultrasound in the diagnosis of asymptomatic catheter‐induced subclavian vein thrombosis. , 1991, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[88]  M. Prins,et al.  A critical review of the evidence supporting a relationship between impaired fibrinolytic activity and venous thromboembolism. , 1991, Archives of internal medicine.

[89]  M Gent,et al.  Canadian Atrial Fibrillation Anticoagulation (CAFA) Study. , 1991, Journal of the American College of Cardiology.

[90]  Lippincott Williams Wilkins,et al.  Stroke Prevention in Atrial Fibrillation Study: Final Results , 1991, Circulation.

[91]  J. Hirsh,et al.  Deep Vein Thrombosis: New Non-Invasive Diagnostic Tests , 1991, Thrombosis and Haemostasis.

[92]  B. Faidutti,et al.  Postoperative chylothorax in children: differences between vascular and traumatic origin. , 1991, Journal of pediatric surgery.

[93]  P. Brill-Edwards,et al.  Subcutaneous Heparin Therapy during Pregnancy: a Need for Concern at the Time of Delivery , 1991, Thrombosis and Haemostasis.

[94]  J. Hirsh Reliability of non-invasive tests for the diagnosis of venous thrombosis. , 1991, Thrombosis and haemostasis.

[95]  H. Büller,et al.  Failure of Computerized Impedance Plethysmography in the Diagnostic Management of Patients with Clinically Suspected Deep-Vein Thrombosis , 1991, Thrombosis and Haemostasis.

[96]  D. Bell,et al.  Cerebral ischemic events associated with endocarditis, retinal vascular disease, and lupus anticoagulant. , 1991, The American journal of medicine.

[97]  E. Gurfinkel,et al.  Comparison of two levels of anticoagulant therapy in patients with substitute heart valves. , 1991, The Journal of thoracic and cardiovascular surgery.

[98]  H. Hoagland,et al.  Essential thrombocythemia in young adults. , 1991, Mayo Clinic proceedings.

[99]  J. Hirsh,et al.  A standard heparin nomogram for the management of heparin therapy. , 1991, Archives of internal medicine.

[100]  M. Monreal,et al.  Upper-extremity deep venous thrombosis and pulmonary embolism. A prospective study. , 1991, Chest.

[101]  J. Hirsh Drug therapy : heparin , 1991 .

[102]  O. Bertel,et al.  Colour coded duplex sonography in suspected deep vein thrombosis of the leg. , 1990, BMJ.

[103]  Bernard Rosner,et al.  The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. , 1990, The New England journal of medicine.

[104]  H. Büller,et al.  Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis. , 1990, The New England journal of medicine.

[105]  F. Rodeghiero,et al.  Thrombotic complications during L-asparaginase treatment for acute lymphocytic leukemia. , 1990, Haematologica.

[106]  D. Carney,et al.  Thromboembolism. A complication of weekly chemotherapy in the treatment of non‐Hodgkin's lymphoma , 1990, Cancer.

[107]  M. Pini,et al.  Subcutaneous vs Intravenous Heparin in the Treatment of Deep Venous Thrombosis – A Randomized Clinical Trial , 1990, Thrombosis and Haemostasis.

[108]  P. Brill-Edwards,et al.  Heparin Effect on Bone Density , 1990, Thrombosis and Haemostasis.

[109]  J. H. van Bockel,et al.  Hereditary Protein S Deficiency in Young Adults with Arterial Occlusive Disease , 1990, Thrombosis and Haemostasis.

[110]  D. Massel,et al.  Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors. , 1990, The Journal of clinical investigation.

[111]  W. Habscheid,et al.  Real-Time Ultrasound in the Diagnosis of Acute Deep Venous Thrombosis of the Lower Extremity , 1990, Angiology.

[112]  Gruppo Italiano per lo Studio della Soprawivenza nell'Inf Miocardico. MEDICAL SCIENCE GISSI-2: A factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12 490 patients with acute myocardial infarction , 1990, The Lancet.

[113]  P. Duffy,et al.  Colour Doppler ultrasound in deep venous thrombosis: a comparison with venography. , 1990, Clinical radiology.

[114]  J. Reading,et al.  Symptomatic lower extremity deep venous thrombosis: accuracy, limitations, and role of color duplex flow imaging in diagnosis. , 1990, Radiology.

[115]  W. Auger,et al.  Chronic major-vessel thromboembolic pulmonary hypertension. , 1990, Circulation.

[116]  P. Investigators,et al.  Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED). , 1990, JAMA.

[117]  G. Raskob,et al.  Heparin for 5 days as compared with 10 days in the initial treatment of proximal venous thrombosis. , 1990, The New England journal of medicine.

[118]  G. Raskob,et al.  Serial Impedance Plethysmography in Pregnant Patients with Clinically Suspected Deep-Vein Thrombosis: Clinical Validity of Negative Findings , 1990 .

[119]  S. Santoro,et al.  Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance. , 1990, Annals of internal medicine.

[120]  A. H. Gorn,et al.  Case 11-1990 , 1990 .

[121]  N. Lindvall,et al.  Osteopenia in pregnancy during long‐term heparin treatment: A radiological study post partum , 1990 .

[122]  T. Barbui,et al.  Incidence and risk factors for thrombotic complications in a historical cohort of 100 patients with essential thrombocythemia. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[123]  A. Gallus,et al.  Trial of different intensities of anticoagulation in patients with prosthetic heart valves. , 1990, The New England journal of medicine.

[124]  Thomas E. Moritz,et al.  Implications of preoperative administration of aspirin in patients undergoing coronary artery bypass grafting. Department of Veterans Affairs Cooperative Study on Antiplatelet Therapy. , 1990, Journal of the American College of Cardiology.

[125]  P. Stevenson,et al.  Preliminary report of the Stroke Prevention in Atrial Fibrillation Study. , 1990, The New England journal of medicine.

[126]  B. Lindblad,et al.  Venous haemodynamics of the upper extremity after subclavian vein thrombosis. , 1990, VASA. Zeitschrift fur Gefasskrankheiten.

[127]  G. Raskob,et al.  Clinical validity of a normal perfusion lung scan in patients with suspected pulmonary embolism. , 1990, Chest.

[128]  A. Comerota,et al.  Venous duplex imaging: should it replace hemodynamic tests for deep venous thrombosis? , 1990, Journal of vascular surgery.

[129]  S. Babu,et al.  Acute adrenal insufficiency and the antiphospholipid syndrome. , 1989, Annals of internal medicine.

[130]  G. Hughes,et al.  The “Primary” Antiphospholipid Syndrome: Major Clinical and Serological Features , 1989, Medicine.

[131]  J. Sánchez-Guerrero,et al.  Antiphospholipid Antibodies and the Antiphospholipid Syndrome in Systemic Lupus Erythematosus A Prospective Analysis of 500 Consecutive Patients , 1989, Medicine.

[132]  G. Delaria,et al.  Inferior vena cava interruption with the Hunter-Sessions balloon: eighteen years' experience in 191 cases. , 1989, Journal of vascular surgery.

[133]  P. Brill-Edwards,et al.  Heparin therapy during pregnancy. Risks to the fetus and mother. , 1989, Archives of internal medicine.

[134]  W. Haire,et al.  Low protein s in essential thrombocythemia with thrombosis , 1989, American journal of hematology.

[135]  P. Wille-Jørgensen,et al.  Prevention of thromboembolism following elective hip surgery. The value of regional anesthesia and graded compression stockings. , 1989, Clinical orthopaedics and related research.

[136]  B. Chong,et al.  Heparin‐induced thrombocytopenia: mechanism of interaction of the heparin‐dependent antibody with platelets , 1989, British journal of haematology.

[137]  J. Hirsh,et al.  Detection of previous proximal venous thrombosis with Doppler ultrasonography and photoplethysmography. , 1989, Archives of internal medicine.

[138]  B. Chong,et al.  The mechanism of heparin‐induced platelet aggregation , 1989, European journal of haematology.

[139]  P. Heckerling,et al.  Retinal vein thrombosis in a patient with pernicious anemia and anticardiolipin antibodies. , 1989, The Journal of rheumatology.

[140]  J. Moreb,et al.  Acquired functional protein S deficiency, cerebral venous thrombosis, and coumarin skin necrosis in association with antiphospholipid syndrome: report of two cases. , 1989, The American journal of medicine.

[141]  L Goldman,et al.  Bleeding in outpatients treated with warfarin: relation to the prothrombin time and important remediable lesions. , 1989, The American journal of medicine.

[142]  L Goldman,et al.  Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatient therapy. , 1989, The American journal of medicine.

[143]  O. Thulesius,et al.  Controversies in the Management of Venous Disorders: Scandinavian Contributions on Venous Problems With Comments by International Authorities , 1989 .

[144]  M. Monreal,et al.  Real-Time Ultrasound for Diagnosis of Symptomatic Venous Thrombosis and for Screening of Patients at Risk: Correlation with Ascending Conventional Venography , 1989, Angiology.

[145]  A. P. Ball,et al.  Low incidence of thrombocytopenia with porcine mucosal heparin. A prospective multicenter study. , 1989, Archives of internal medicine.

[146]  B. Chong,et al.  Heparin-induced thrombocytopenia: studies with a new low molecular weight heparinoid, Org 10172 , 1989 .

[147]  E. R. Jewell,et al.  Use of the triplex scanner in diagnosis of deep venous thrombosis. , 1989, Archives of surgery.

[148]  D. Lane,et al.  Heparin: Chemical and Biological Properties Clinical Applications , 1989 .

[149]  G. Hughes,et al.  Antiphospholipid antibodies: a risk factor for occlusive ocular vascular disease in systemic lupus erythematosus and the 'primary' antiphospholipid syndrome. , 1989, Annals of the rheumatic diseases.

[150]  M. Walport,et al.  Primary antiphospholipid syndrome: features of patients with raised anticardiolipin antibodies and no other disorder. , 1989, Annals of the rheumatic diseases.

[151]  S. Carette,et al.  Acute adrenal insufficiency as a manifestation of the anticardiolipin syndrome? , 1989, Annals of the rheumatic diseases.

[152]  M. Levine,et al.  Risks to the fetus of anticoagulant therapy during pregnancy. , 1989, Thrombosis and haemostasis.

[153]  B. Wechsler,et al.  Systemic lupus erythematosus presenting with portal venous thrombosis. , 1989, The American journal of medicine.

[154]  A. Montoya,et al.  Management of Blood Loss and Heparin Rebound Following Cardiopulmonary Bypass , 1989, Seminars in thrombosis and hemostasis.

[155]  I. Yada,et al.  Alterations in coagulation and fibrinolysis associated with cardiopulmonary bypass during open heart surgery. , 1989, Journal of cardiothoracic anesthesia.

[156]  J. Hirsh,et al.  A randomized trial of less intense postoperative warfarin or aspirin therapy in the prevention of venous thromboembolism after surgery for fractured hip. , 1989, Archives of internal medicine.

[157]  H. Büller,et al.  Management of clinically suspected acute venous thrombosis in outpatients with serial impedance plethysmography in a community hospital setting. , 1989, Archives of internal medicine.

[158]  J. Cronan,et al.  Recurrent deep venous thrombosis: limitations of US. , 1989, Radiology.

[159]  J. Hirsh,et al.  Prevention of deep vein thrombosis in potential neurosurgical patients. A randomized trial comparing graduated compression stockings alone or graduated compression stockings plus intermittent pneumatic compression with control. , 1989, Archives of internal medicine.

[160]  Abdelwahab Omri,et al.  Low Molecular Weight Heparin Novo (LHN-1) Does Not Cross the Placenta During the Second Trimester of Pregnancy , 1989, Thrombosis and Haemostasis.

[161]  P. Callas,et al.  The clinical spectrum of heterozygous protein C deficiency in a large New England kindred. , 1989, Blood.

[162]  H. Büller,et al.  Detection of deep-vein thrombosis by real-time B-mode ultrasonography. , 1989, The New England journal of medicine.

[163]  A. Vagnucci,et al.  Bilateral massive adrenal hemorrhage: early recognition and treatment. , 1989, Annals of internal medicine.

[164]  S. Erickson,et al.  Color Doppler ultrasound imaging of lower-extremity venous disease. , 1989, AJR. American journal of roentgenology.

[165]  Palle Petersen,et al.  PLACEBO-CONTROLLED, RANDOMISED TRIAL OF WARFARIN AND ASPIRIN FOR PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN CHRONIC ATRIAL FIBRILLATION The Copenhagen AFASAK Study , 1989, The Lancet.

[166]  E. Kruithof,et al.  Necrosis of skin induced by coumarin in a patient deficient in protein S. , 1989, BMJ.

[167]  G. Yarkony,et al.  Fixed- vs adjusted-dose heparin in the prophylaxis of thromboembolism in spinal cord injury. , 1988, JAMA.

[168]  J. Kelton,et al.  Heparin-induced thrombocytopenia: laboratory studies. , 1988, Blood.

[169]  J. Bormanis,et al.  Ancrod: a practical alternative to heparin. , 1988, Journal of vascular surgery.

[170]  J. Hirsh,et al.  RANDOMISED COMPARISON OF TWO INTENSITIES OF ORAL ANTICOAGULANT THERAPY AFTER TISSUE HEART VALVE REPLACEMENT , 1988, The Lancet.

[171]  B. Lindblad,et al.  Deep Vein Thrombosis of the Axillary-subclavian Veins: Epidemiologic Data, Effects of Different Types of Treatment and Late Sequele , 1988 .

[172]  V. Hoffstein,et al.  Fatal pulmonary emboli in hospitalized patients. An autopsy study. , 1988, Archives of internal medicine.

[173]  R. Collins,et al.  Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery. , 1988, The New England journal of medicine.

[174]  P. D. de Groot,et al.  Coagulation screen is more specific than the anticardiolipin antibody ELISA in defining a thrombotic subset of lupus patients. , 1988, Annals of the rheumatic diseases.

[175]  G. Raskob,et al.  Pulmonary embolism in outpatients with pleuritic chest pain. , 1988, Archives of internal medicine.

[176]  J. Hirsh Utility of impedance plethysmography in the diagnosis of recurrent deep-vein thrombosis. , 1988 .

[177]  J. Griffin,et al.  The Frequency of Type I Heterozygous Protein S and Protein C Deficiency in 141 Unrelated Young Patients with Venous Thrombosis , 1988, Thrombosis and Haemostasis.

[178]  J. Hirsh,et al.  The thrombogenic effect of anticancer drug therapy in women with stage II breast cancer. , 1988, The New England journal of medicine.

[179]  D. Evans,et al.  Changing concepts of deep venous thrombosis of the upper extremity--report of a series and review of the literature. , 1988, Surgery.

[180]  J. Brandt,et al.  The relationship between lupus anticoagulants and antibodies to phospholipid. , 1988, JAMA.

[181]  C. Kitchens Prolonged activated partial thromboplastin time of unknown etiology: A prospective study of 100 consecutive cases referred for consultation , 1988, American journal of hematology.

[182]  Triplett Da,et al.  Lupus anticoagulants: misnomer, paradox, riddle, epiphenomenon. , 1988 .

[183]  D. Mikhailidis,et al.  Comparison of the platelet pro‐aggregatory effect of conventional unfractionated heparins and a low molecular weight heparin fraction (CY 222) , 1987, British journal of haematology.

[184]  S. Polansky,et al.  Effect of heparin infusates in umbilical arterial catheters on frequency of thrombotic complications. , 1987, The Journal of pediatrics.

[185]  K. Peterson,et al.  Thromboendarterectomy for chronic, major-vessel thromboembolic pulmonary hypertension. Immediate and long-term results in 42 patients. , 1987, Annals of internal medicine.

[186]  D. Doyle,et al.  Adjusted subcutaneous heparin or continuous intravenous heparin in patients with acute deep vein thrombosis. A randomized trial. , 1987, Annals of internal medicine.

[187]  B. Coller,et al.  Deficiency of Plasma Protein S, Protein C, or Antithrombin III and Arterial Thrombosis , 1987, Arteriosclerosis.

[188]  K. Welch,et al.  Cerebral venous thrombosis with lupus anticoagulants. Report of two cases. , 1987, Stroke.

[189]  R. Jeffrey,et al.  Deep venous thrombosis of the lower extremity: US evaluation. , 1987, Radiology.

[190]  M. Walker,et al.  Subcutaneous calcium heparin versus intravenous sodium heparin in treatment of established acute deep vein thrombosis of the legs: a multicentre prospective randomised trial. , 1987, British medical journal.

[191]  E. Briët,et al.  Hereditary protein S deficiency: clinical manifestations. , 1987, Annals of internal medicine.

[192]  F. Daffos,et al.  Low Molecular Weight Heparin (CY 216) Does Not Cross the Placenta During the Third Trimester of Pregnancy , 1987, Thrombosis and Haemostasis.

[193]  A. Elias,et al.  Value of real time B mode ultrasound imaging in the diagnosis of deep vein thrombosis of the lower limbs. , 1987, International angiology : a journal of the International Union of Angiology.

[194]  F. Holmes,et al.  Local infusion of urokinase for the lysis of thrombosis associated with permanent central venous catheters in cancer patients. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[195]  S. Tannenbaum,et al.  Immune endothelial-cell injury in heparin-associated thrombocytopenia. , 1987, The New England journal of medicine.

[196]  J. Cronan,et al.  Deep venous thrombosis: US assessment using vein compression. , 1987, Radiology.

[197]  R. Colman,et al.  Hemostasis and Thrombosis: Basic Principles and Clinical Practice , 1988 .

[198]  G. Raskob,et al.  Hemorrhagic complications of long-term anticoagulant therapy. , 1986, Chest.

[199]  A. Wycherley,et al.  SAFETY AND EFFICACY OF WARFARIN STARTED EARLY AFTER SUBMASSIVE VENOUS THROMBOSIS OR PULMONARY EMBOLISM , 1986, The Lancet.

[200]  L. Greenfield,et al.  Greenfield vena caval filter: rationale and current indications. , 1986, The Annals of thoracic surgery.

[201]  E. Salazar,et al.  Risks of anticoagulant therapy in pregnant women with artificial heart valves. , 1986, The New England journal of medicine.

[202]  M. Dauzat,et al.  Real‐time B‐mode ultrasonography for better specificity in the noninvasive diagnosis of deep venous thrombosis. , 1986, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[203]  G. Raskob,et al.  Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis. , 1986, The New England journal of medicine.

[204]  G. Delclos,et al.  Thrombolytic therapy for pulmonary embolism in pregnancy: a case report. , 1986, American journal of obstetrics and gynecology.

[205]  S. Wilson,et al.  Pathogenesis determines late morbidity of axillosubclavian vein thrombosis. , 1986, American journal of surgery.

[206]  T. Bjornsson,et al.  Variability in heparin sensitivity of APTT reagents. , 1986, American journal of clinical pathology.

[207]  D. Bernstein,et al.  Pulmonary embolism in adolescents. , 1986, American journal of diseases of children.

[208]  M. Aiach,et al.  LOW‐MOLECULAR‐WEIGHT HEPARIN IN VEINOUS THROMBOSIS DURING PREGNANCY , 1986, British journal of haematology.

[209]  R. Bertina,et al.  Protein S Deficiency Associated with “Juvenile” Arterial and Venous Thromboses , 1986, Thrombosis and Haemostasis.

[210]  R. T. Bailey,et al.  Heparin-Associated Thrombocytopenia: A Prospective Comparison of Bovine Lung Heparin, Manufactured by a New Process, and Porcine Intestinal Heparin , 1986, Drug intelligence & clinical pharmacy.

[211]  N. Zauber,et al.  Successful warfarin anticoagulation despite protein C deficiency and a history of warfarin necrosis. , 1986, Annals of internal medicine.

[212]  H. Büller,et al.  Thrombosis Prophylaxis in an AT III Deficient Pregnant Woman: Application of a Low Molecular Weight Heparinoid , 1986, Thrombosis and Haemostasis.

[213]  H. Büller,et al.  Serial impedance plethysmography for suspected deep venous thrombosis in outpatients. The Amsterdam General Practitioner Study. , 1986, The New England journal of medicine.

[214]  R. Pepperell Suppression of lactation , 1986, The Medical journal of Australia.

[215]  J. Kelton,et al.  A diagnostic test for heparin-induced thrombocytopenia , 1986 .

[216]  A. Girolami,et al.  Congenital heterozygous plasminogen deficiency associated with a severe thrombotic tendency. , 1986, Acta haematologica.

[217]  E. Bosque,et al.  Continuous versus intermittent heparin infusion of umbilical artery catheters in the newborn infant. , 1986, The Journal of pediatrics.

[218]  Denise H. Kinch,et al.  Diagnostic efficacy of impedance plethysmography for clinically suspected deep-vein thrombosis. A randomized trial. , 2020, Annals of internal medicine.

[219]  B. Ljungberg,et al.  One-month versus six-month therapy with oral anticoagulants after symptomatic deep vein thrombosis. , 2009, Acta medica Scandinavica.

[220]  S. Schulman,et al.  The duration of oral anticoagulation after deep vein thrombosis. A randomized study. , 2009, Acta medica Scandinavica.

[221]  J. Ansell,et al.  Heparin-induced thrombocytopenia. What is its real frequency? , 1985, Chest.

[222]  C J Carter,et al.  Diagnostic value of ventilation-perfusion lung scanning in patients with suspected pulmonary embolism. , 1985, Chest.

[223]  M. Bettmann,et al.  Evaluation of optimized biplane pulmonary cineangiography. , 1985, Investigative radiology.

[224]  W. Hix,et al.  Lytic therapy in the treatment of axillary and subclavian vein thrombosis. , 1985, Journal of vascular surgery.

[225]  P. Ohlin,et al.  Pulmonary embolism in acute iliofemoral venous thrombosis , 1985, The British journal of surgery.

[226]  I. Pabinger-Fasching,et al.  Protein C deficiency in Austria. , 1985, Seminars in thrombosis and hemostasis.

[227]  U. Albrechtsson,et al.  NEED FOR LONG-TERM ANTICOAGULANT TREATMENT IN SYMPTOMATIC CALF-VEIN THROMBOSIS , 1985, The Lancet.

[228]  D. Reede,et al.  Trousseau's syndrome in the head and neck. , 1985, American journal of otolaryngology.

[229]  M. Witte,et al.  Protean Manifestations of Pylethrombosis: A Review of Thirty‐Four Patients , 1985, Annals of surgery.

[230]  M. A. Miller,et al.  Thrombosis in systemic lupus erythematosus. Relation to the presence of circulating anticoagulants. , 1985, Archives of internal medicine.

[231]  P. Wille-Jørgensen,et al.  Heparin with and without graded compression stockings in the prevention of thromboembolic complications of major abdominal surgery: A randomized trial , 1985, The British journal of surgery.

[232]  J. Weiler,et al.  Protamine-induced fatal anaphylaxis. Prevalence of antiprotamine immunoglobulin E antibody. , 1985, The Journal of thoracic and cardiovascular surgery.

[233]  D. Gastineau,et al.  Lupus anticoagulant: An analysis of the clinical and laboratory features of 219 cases , 1985, American journal of hematology.

[234]  R. Rochat,et al.  Causes of Maternal Mortality in the United States , 1985, Obstetrics and gynecology.

[235]  T O McNamara,et al.  Thrombolysis of peripheral arterial and graft occlusions: improved results using high-dose urokinase. , 1985, AJR. American journal of roentgenology.

[236]  J. Walenga,et al.  Biochemical and Pharmacologic Studies on the Protamine Interactions with Heparin, Its Fractions and Fragments , 1985, Seminars in thrombosis and hemostasis.

[237]  K. Lechner,et al.  Lupus Anticoagulants and Thrombosis , 1985 .

[238]  H. Wilson,et al.  Neonatal purpura fulminans: a genetic disorder related to the absence of protein C in blood. , 1985, Blood.

[239]  B. Gårdlund The lupus inhibitor in thromboembolic disease and intrauterine death in the absence of systemic lupus. , 2009, Acta medica Scandinavica.

[240]  J. B. Kneeland,et al.  MR, CT, and ultrasonographic demonstration of splenic vein thrombosis. , 1984, Journal of computer assisted tomography.

[241]  S. Mulvihill,et al.  Complications of superior versus inferior vena cava occlusion in infants receiving central total parenteral nutrition. , 1984, Journal of pediatric surgery.

[242]  M. Samama,et al.  Congenital protein C deficiency and thrombotic disease in nine French families. , 1984, British medical journal.

[243]  J. Hirsh,et al.  Outcome of abnormal impedance plethysmography results in patients with proximal-vein thrombosis: frequency of return to normal. , 1984, Thrombosis research.

[244]  M. Karpf,et al.  Deep Venous Thrombosis of the Upper Extremity Five Years Experience at a University Hospital , 1984, Angiology.

[245]  S. Gitel,et al.  Warfarin. From bedside to bench. , 1984, The New England journal of medicine.

[246]  G. Martin,et al.  Thrombocytopenia in a prospective, randomized, double-blind trial of bovine and porcine heparin. , 1984, The American journal of the medical sciences.

[247]  R. Montgomery,et al.  Severe homozygous protein C deficiency. , 1984, The Journal of pediatrics.

[248]  S. Horii,et al.  Deep venous thrombosis: detection by high-resolution real-time ultrasonography. , 1984, Radiology.

[249]  G. Raskob,et al.  The diagnosis of clinically suspected venous thrombosis. , 1984, Clinics in chest medicine.

[250]  J. Alpert,et al.  The natural history of pulmonary embolism. , 1984, Clinics in chest medicine.

[251]  F. España,et al.  Severe Inherited “Homozygous” Protein C Deficiency in a Newborn Infant , 1984, Thrombosis and Haemostasis.

[252]  C. Presant,et al.  Iatrogenic superior vena cava syndrome. A new entity , 1984, Cancer.

[253]  F. Daffos,et al.  Low molecular weight heparin (PK 10169) does not cross the placenta during the second trimester of pregnancy study by direct fetal blood sampling under ultrasound. , 1984, Thrombosis research.

[254]  J. Vacanti,et al.  Fatal pulmonary embolism following removal of a central venous catheter. , 1984, Journal of pediatric surgery.

[255]  R. Cipolle,et al.  Heparin‐induced thrombocytopenia in patients with cerebrovascular ischemic disease , 1984, Neurology.

[256]  D. T. Liu,et al.  Severe heparin osteoporosis in pregnancy. , 1984, Postgraduate medical journal.

[257]  G. Mintz,et al.  Renal vein thrombosis and inferior vena cava thrombosis in systemic lupus erythematosus , 1984 .

[258]  T. Burnakis,et al.  Transaminase elevations in patients receiving bovine or porcine heparin. , 1984, Annals of internal medicine.

[259]  J. Roehm The bird's nest filter: a new percutaneous transcatheter inferior vena cava filter. , 1984, Journal of vascular surgery.

[260]  Appleby Dh,et al.  Low-dose streptokinase therapy for subclavian vein thrombosis. , 1984 .

[261]  J. Kelton,et al.  Clinical usefulness of testing for a heparin-dependent platelet-aggregating factor in patients with suspected heparin-associated thrombocytopenia. , 1984, The Journal of laboratory and clinical medicine.

[262]  J. J. Wilson,et al.  Subclavian-axillary vein thrombosis: successful treatment with streptokinase. , 1984, Canadian Medical Association journal.

[263]  W. James Trousseau's Syndrome , 1984, International journal of dermatology.

[264]  D. J. King,et al.  Heparin-associated thrombocytopenia. , 1984, Annals of internal medicine.

[265]  J. Buring,et al.  Pooled analyses of randomized trials of streptokinase and heparin in phlebographically documented acute deep venous thrombosis. , 1984, The American journal of medicine.

[266]  J. Soria,et al.  Successful Progressive Anticoagulation in a Severe Protein C Deficiency and Previous Skin Necrosis at the Initiation of Oral Anticoagulant Treatment , 1984, Thrombosis and Haemostasis.

[267]  J. Kelton,et al.  Studies on the frequency of heparin-associated thrombocytopenia. , 1984, Thrombosis research.

[268]  C. Gumbiner,et al.  Right atrial thrombus and superior vena cava syndrome in a child. , 1984, Pediatrics.

[269]  J. Hirsh Heparin induced bleeding. , 1984, Nouvelle revue francaise d'hematologie.

[270]  C. Mackworth-Young,et al.  ANTICARDIOLIPIN ANTIBODIES: DETECTION BY RADIOIMMUNOASSAY AND ASSOCIATION WITH THROMBOSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS , 1983, The Lancet.

[271]  J. Katz,et al.  INHERITED PROTEIN C DEFICIENCY AND COUMARIN-RESPONSIVE CHRONIC RELAPSING PURPURA FULMINANS IN A NEWBORN INFANT , 1983, The Lancet.

[272]  J. Glover,et al.  Local thrombolytic therapy for subclavian and axillary vein thrombosis. Treatment of the thoracic inlet syndrome. , 1983, Radiology.

[273]  P. Leyvraz,et al.  Adjusted versus fixed-dose subcutaneous heparin in the prevention of deep-vein thrombosis after total hip replacement. , 1983, The New England journal of medicine.

[274]  E. Massey,et al.  Neurologic manifestations of essential thrombocythemia. , 1983, Annals of internal medicine.

[275]  D. Strandness,et al.  Long-term sequelae of acute venous thrombosis. , 1983, JAMA.

[276]  R. Bertina,et al.  Congenital protein C deficiency and venous thromboembolism. A study of three Dutch families. , 1983, The New England journal of medicine.

[277]  D. Skinner,et al.  Warfarin necrosis of the skin and subcutaneous tissue of the male external genitalia. , 1983, The Journal of urology.

[278]  D. Mollitt,et al.  Complications of TPN catheter-induced vena caval thrombosis in children less than one year of age. , 1983, Journal of pediatric surgery.

[279]  U. Vasan,et al.  Is warfarin sodium contraindicated in the lactating mother? , 1983, The Journal of pediatrics.

[280]  J. Kattwinkel,et al.  Recurrent bilateral pleural effusions secondary to superior vena cava obstruction as a complication of central venous catheterization. , 1983, Pediatrics.

[281]  R. Bertina,et al.  Protein C and the Development of Skin Necrosis During Anticoagulant Therapy , 1983, Thrombosis and Haemostasis.

[282]  C J Carter,et al.  Pulmonary angiography, ventilation lung scanning, and venography for clinically suspected pulmonary embolism with abnormal perfusion lung scan. , 1983, Annals of internal medicine.

[283]  R. Cipolle,et al.  Heparin-associated thrombocytopenia: a prospective evaluation of 211 patients. , 1983, Therapeutic drug monitoring.

[284]  V. Fuster,et al.  Trial of combined warfarin plus dipyridamole or aspirin therapy in prosthetic heart valve replacement: danger of aspirin compared with dipyridamole. , 1983, The American journal of cardiology.

[285]  Hallett Jw,et al.  Subclavian vein thrombosis during prolonged catheterization for parenteral nutrition: early management and long-term follow-up. , 1983 .

[286]  M. Gent,et al.  The Diagnosis of Acute, Recurrent, Deep‐vein Thrombosis: A Diagnostic Challenge , 1983, Circulation.

[287]  C. Francis,et al.  Two-step warfarin therapy. Prevention of postoperative venous thrombosis without excessive bleeding. , 1983, JAMA.

[288]  H. Bingham,et al.  Heparin-induced thrombocytopenia, thrombosis, and hemorrhage , 1980 .

[289]  G. Raskob,et al.  Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis. , 1982, The New England journal of medicine.

[290]  G. Den Ottolander,et al.  Home-Diagnosis of Deep Venous Thrombosis with Impedance Plethysmography , 1982, Thrombosis and Haemostasis.

[291]  P. Frick,et al.  Repeated Occurrence of Skin Necrosis Twice Following Coumarin Intake and Subsequently During Decrease of Vitamin K Dependent Coagulation Factors Associated with Cholestasis , 1982, Thrombosis and Haemostasis.

[292]  B. Chong,et al.  HEPARIN-INDUCED THROMBOCYTOPENIA: ASSOCIATION OF THROMBOTIC COMPLICATIONS WITH HEPARIN-DEPENDENT IgG ANTIBODY THAT INDUCES THROMBOXANE SYNTHESIS AND PLATELET AGGREGATION , 1982, The Lancet.

[293]  C. D. de Swart,et al.  Kinetics of intravenously administered heparin in normal humans. , 1982, Blood.

[294]  W. Hickey,et al.  Primary cerebral venous thrombosis in patients with cancer--a rarely diagnosed paraneoplastic syndrome. Report of three cases and review of the literature. , 1982, The American journal of medicine.

[295]  H. Schaff,et al.  Cardiovascular effects of protamine sulfate in man. , 1982, The Journal of thoracic and cardiovascular surgery.

[296]  W. Ashburn,et al.  Longterm follow-up of patients with suspected pulmonary embolism and a normal lung scan. Perfusion scans in embolic suspects. , 1982, Chest.

[297]  B. Ljungberg,et al.  Subcutaneous administration of heparin. A randomised comparison with intravenous administration of heparin to patients with deep-vein thrombosis. , 1982, Thrombosis research.

[298]  N. Patwardhan,et al.  Suspected deep vein thrombosis. Management by impedance plethysmography. , 1982 .

[299]  T. Simon,et al.  Current status of pulmonary thromboembolic disease: pathophysiology, diagnosis, prevention, and treatment. , 1982, American heart journal.

[300]  J. Hirsh,et al.  Adjusted subcutaneous heparin versus warfarin sodium in the long-term treatment of venous thrombosis. , 1982, The New England journal of medicine.

[301]  T. Bjornsson,et al.  Heparin kinetics determined by three assay methods , 1982, Clinical pharmacology and therapeutics.

[302]  D. Leehey,et al.  Heparin-induced hypoaldosteronism. Report of a case. , 1981, JAMA.

[303]  S. Kramer,et al.  Lethal chylothoraces due to superior vena caval thrombosis in infants. , 1981, AJR. American journal of roentgenology.

[304]  D. Sackett,et al.  Clinical Validity of a Negative Venogram in Patients with Clinically Suspected Venous Thrombosis , 1981, Circulation.

[305]  R. Marlar,et al.  HUMAN PROTEIN C: INACTIVATION OF FACTORS V AND VIII IN PLASMA BY THE ACTIVATED MOLECULE * , 1981, Annals of the New York Academy of Sciences.

[306]  K. Lechner,et al.  Antithrombin III deficiency and thromboembolism. , 1981, Clinics in haematology.

[307]  D. DeMets,et al.  History and physical examination in acute pulmonary embolism in patients without preexisting cardiac or pulmonary disease. , 1981, The American journal of cardiology.

[308]  J. C. Anderson,et al.  Prevention of umbilical artery catheter clots with heparinized infusates. , 1981, Developmental pharmacology and therapeutics.

[309]  W. McCartney,et al.  The role of noninvasive tests versus pulmonary angiography in the diagnosis of pulmonary embolism. , 1981, The American journal of medicine.

[310]  M. Rubenstein,et al.  Successful streptokinase therapy for catheter-induced subclavian vein thrombosis. , 1980, Archives of internal medicine.

[311]  P. Wise,et al.  Heparin-induced osteopenia in pregnancy. , 1980, British medical journal.

[312]  D. Collen On the Regulation and Control of Fibrinolysis , 1980, Thrombosis and Haemostasis.

[313]  E. Myhre,et al.  Bleeding during acetylsalicylic acid and anticoagulant therapy in patients with reduced platelet reactivity after aortic valve replacement. , 1980, American heart journal.

[314]  B J McNeil,et al.  Ventilation-perfusion studies and the diagnosis of pulmonary embolism: concise communication. , 1980, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[315]  J. Ansell,et al.  Heparin Induced Thrombocytopenia: a Prospective Study , 1980, Thrombosis and Haemostasis.

[316]  E. Salzman,et al.  Prophylaxis of Venous Thromboembolism: Analysis of Cost Effectiveness , 1980, Annals of surgery.

[317]  A. Gallus,et al.  Heparin-associated thrombocytopenia: case report and prospective study. , 1980, Australian and New Zealand journal of medicine.

[318]  M. Steer,et al.  Thromboembolism after insertion of the Mobin-Uddin caval filter. , 1980, Surgery.

[319]  J. Lumley,et al.  Better perinatal health. Australia. , 1980, Lancet.

[320]  P. G. Bentley,et al.  An objective study of alternative methods of heparin administration. , 1980, Thrombosis Research.

[321]  R. Pauli,et al.  Maternal and fetal sequelae of anticoagulation during pregnancy. , 1980, The American journal of medicine.

[322]  K. Phelps,et al.  Heparin-induced hyperkalemia: report of a case. , 1980, Nephron.

[323]  R. Rosenberg,et al.  Effect of heparin and heparin fractions on platelet aggregation. , 1980, The Journal of clinical investigation.

[324]  S. Benatar,et al.  A comparative randomized trial of heparin versus streptokinase in the treatment of acute proximal venous thrombosis: An interim report of a prospective trial , 1979, The British journal of surgery.

[325]  B. Siegel,et al.  Ventilation-perfusion studies in suspected pulmonary embolism. , 1979, AJR. American journal of roentgenology.

[326]  P. White,et al.  Thrombotic Complications of Heparin Therapy Including Six Cases of Heparin‐Induced Skin Necrosis , 1979, Annals of surgery.

[327]  A. Nicolaides,et al.  Significance of popliteal reflux in relation to ambulatory venous pressure and ulceration. , 1979, Archives of surgery.

[328]  M Gent,et al.  Warfarin sodium versus low-dose heparin in the long-term treatment of venous thrombosis. , 1979, The New England journal of medicine.

[329]  L. Pinch,et al.  Heparin-induced spinal fractures. , 1979, JAMA.

[330]  J. Hirsh,et al.  Thrombocytopenia found uncommonly during heparin therapy. , 1979, JAMA.

[331]  A. Nicolaides,et al.  Ambulatory calf volume plethysmography in the assessment of venous insufficiency , 1979, The British journal of surgery.

[332]  R. Wennberg,et al.  Effect of heparinization of fluids infused through an umbilical artery catheter on catheter patency and frequency of complications. , 1979, Pediatrics.

[333]  J. Wilson,et al.  Heparin therapy: a randomized prospective study. , 1979, American heart journal.

[334]  L. Sherman,et al.  Venous and arterial thrombosis : pathogenesis, diagnosis, prevention, and therapy , 1979 .

[335]  A. Udén,et al.  Thromboembolic complications following scoliosis surgery in Scandinavia. , 1979, Acta orthopaedica Scandinavica.

[336]  J. Hirsh,et al.  Effectiveness of intermittent pulsatile elastic stockings for the prevention of calf and thigh vein thrombosis in patients undergoing elective knee surgery. , 1979, Thrombosis research.

[337]  V. Bernhard,et al.  Comparison of caval filters in the management of venous thromboembolism. , 1978, Archives of surgery.

[338]  K. Giercksky,et al.  An Immunoradiometric Assay for Factor III (Tissue Thromboplastin) , 1978, British journal of haematology.

[339]  H. Yett,et al.  The hazards of aspirin plus heparin. , 1978, The New England journal of medicine.

[340]  L. Greenfield,et al.  Entrapment of sized emboli by the KMA-Greenfield intracaval filter. , 1978, Surgery.

[341]  R. Lerner,et al.  Heparin-induced thrombocytopenia. , 1978, Archives of internal medicine.

[342]  K. Mckusick,et al.  The clinical course of patients with suspected pulmonary embolism and a negative pulmonary arteriogram. , 1978, Radiology.

[343]  C. Axelsson,et al.  Phlebography in long-term catheterization of the subclavian vein. A retrospective study in patients with severe gastrointestinal disorders. , 1978, Scandinavian journal of gastroenterology.

[344]  W. Kisiel,et al.  Anticoagulant properties of bovine plasma protein C following activation by thrombin. , 1977, Biochemistry.

[345]  Bernstein Ef,et al.  Axillary, subclavian, and brachiocephalic vein obstruction. , 1977 .

[346]  Provan Jl,et al.  Control and complications of intermittent heparin therapy. , 1977 .

[347]  A. Singh,et al.  Microvascular Occlusive Lesions in Primary Thrombocythaemia , 1977, British journal of haematology.

[348]  P. G. Bentley,et al.  Femoral vein thrombosis and total hip replacement. , 1977, British medical journal.

[349]  A. Breckenridge,et al.  May mothers given warfarin breast-feed their infants? , 1977, British medical journal.

[350]  R. Hall,et al.  Pulmonary embolectomy, heparin, and streptokinase: their place in the treatment of acute massive pulmonary embolism. , 1977, American heart journal.

[351]  T. O'donnell,et al.  The socioeconomic effects of an iliofemoral venous thrombosis. , 1977, The Journal of surgical research.

[352]  D. DeMets,et al.  The clinical features of submassive and massive pulmonary emboli. , 1977, Obstetrical & gynecological survey.

[353]  J. Hirsh,et al.  Relationship between the anticoagulant and antithrombotic effects of heparin in experimental venous thrombosis. , 1977, Blood.

[354]  J. Levin,et al.  Trousseau's syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms: clinical, pathophysiologic, and therapeutic features. , 1977, Medicine.

[355]  J. Hirsh,et al.  Prevention of Venous Thromboembolism , 1976 .

[356]  T. Simon,et al.  A comparative analysis of pulmonary perfusion scans with pulmonary angiograms. , 1976, American heart journal.

[357]  J. Rösch,et al.  Deep Vein Thrombosis Treated With Streptokinase or Heparin , 1976, Angiology.

[358]  E. Crowell,et al.  Randomized prospective trial of continuous vs intermittent heparin therapy. , 1976, JAMA.

[359]  P. Alderson,et al.  The role of 133Xe ventilation studies in the scintigraphic detection of pulmonary embolism. , 1976, Radiology.

[360]  J. Hirsh,et al.  Treatment of venous thromboembolic disease. , 1976, Seminars in thrombosis and hemostasis.

[361]  M Gent,et al.  Diagnosis of Venous Thrombosis , 2005 .

[362]  C. Dollery,et al.  Heparin Kinetics in Venous Thrombosis and Pulmonary Embolism , 1976, Circulation.

[363]  George Rh,et al.  Letter: Gentamicin resistance. , 1976 .

[364]  Rosenberg Rd,et al.  Alpha 2-macroglobulin and antithrombin-heparin cofactor: modulators of hemostatic and inflammatory reactions. Alpha 2-macroglobulin. , 1976 .

[365]  J. Petasnick,et al.  Therapeutic balloon occlusion of the inferior vena cava. , 1975, JAMA.

[366]  E W Salzman,et al.  Management of heparin therapy: Controlled prospective trial. , 1975, The New England journal of medicine.

[367]  B. C. Penney,et al.  Bedside Screening for Venous Thrombosis Using Occlusive Impedance Phlebography , 1975, Angiology.

[368]  L. Avioli,et al.  Heparin-induced osteopenia: an appraisal. , 1975, Advances in experimental medicine and biology.

[369]  Kakkar Vv,et al.  Plethysmographic diagnosis of deep vein thrombosis. , 1974 .

[370]  V. Kakkar,et al.  Phlebography in the management of pulmonary embolism , 1974, The British journal of surgery.

[371]  N. Ellison,et al.  Heparin rebound. Studies in patients and volunteers. , 1974, The Journal of thoracic and cardiovascular surgery.

[372]  D. Croft,et al.  Fibrinogen-Detectable Thrombosis in the Legs and Pulmonary Embolism , 1974, British medical journal.

[373]  J. Anderson,et al.  Comparison by Controlled Clinical Trial of Streptokinase and Heparin in Treatment of Life-threatening Pulmonary Embolism , 1974, British medical journal.

[374]  N. Browse,et al.  Occasional Survey: SOURCE OF NON-LETHAL PULMONARY EMBOLI , 1974 .

[375]  Coon Ww Operative therapy of venous thromboembolism. , 1974 .

[376]  T. M. Silver,et al.  The angiographic differential diagnosis of acute pulmonary embolism. , 1974, Radiology.

[377]  William Grossman,et al.  Cardiac catheterization and angiography , 1974 .

[378]  J. Todd,et al.  Spontaneous, lower-extremity venous thrombosis in children. , 1973, American journal of diseases of children.

[379]  J. Keller,et al.  Venous Thromboembolism and Other Venous Disease in the Tecumseh Community Health Study , 1973, Circulation.

[380]  R. Hall,et al.  Treatment of Acute Massive Pulmonary Embolism by Streptokinase during Labour and Delivery , 1972, British medical journal.

[381]  O'Sullivan Ef Duration of anticoagulant therapy in venous thrombo--embolism. , 1972 .

[382]  J. Hirsh,et al.  A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time. , 1972, The New England journal of medicine.

[383]  K. Rabinov,et al.  Roentgen diagnosis of venous thrombosis in the leg. , 1972, Archives of surgery.

[384]  H B Wheeler,et al.  Impedance phlebography: technique, interpretation, and results. , 1972, Archives of surgery.

[385]  J. Jude,et al.  Transvenous caval interruption with umbrella filter. , 1972, The New England journal of medicine.

[386]  J. Deweese,et al.  "Effort" thrombosis of the axillary and subclavian veins. , 1971, The Journal of trauma.

[387]  A. Nicolaides,et al.  The origin of deep vein thrombosis: a venographic study. , 1971, The British journal of radiology.

[388]  P. Durante,et al.  Reversible interruption of inferior vena cava by means of a balloon catheter. Preliminary report. , 1971, The Journal of thoracic and cardiovascular surgery.

[389]  G. Sutton,et al.  Comparison of Streptokinase and Heparin in Treatment of Isolated Acute Massive Pulmonary Embolism* , 1971, British heart journal.

[390]  C. Moschos,et al.  Thrombogenic properties of blood during early ischemic and nonischemic injury. , 1971, The American journal of physiology.

[391]  L. Dexter,et al.  Diagnostic senstivity of laboratory findings in acute pulmonary embolism. , 1971, Annals of internal medicine.

[392]  E. A. Edwards,et al.  Natural History of Major Venous Thrombosis of the Upper Extremity , 1970 .

[393]  A. Nicolaides,et al.  Deep vein thrombosis of the leg , 1970 .

[394]  D. Negus The post-thrombotic syndrome. , 1970, Annals of the Royal College of Surgeons of England.

[395]  M. Gyepes,et al.  Transfemoral selective bilateral pulmonary arteriography with a pulmonary-artery-seeking catheter. , 1970, Radiology.

[396]  Simon Sevitt,et al.  Venous Thrombosis and Pulmonary Embolism , 1970 .

[397]  J. Bookstein Segmental arteriography by pulmonary embolism. , 1969, Radiology.

[398]  V. Kakkar,et al.  Natural history of postoperative deep-vein thrombosis. , 1969, Lancet.

[399]  W. Ostermiller,et al.  Mesenteric venous thrombosis secondary to polycythemia vera. , 1969, The American surgeon.

[400]  K. Haeger,et al.  Problems of Acute Deep Venous Thrombosis , 1969, Angiology.

[401]  C. Bray,et al.  Acquired resistance to treatment with arvin. , 1969, Lancet.

[402]  S. Wessler,et al.  On the mechanism of thrombosis. , 1969, Progress in hematology.

[403]  J. Canby PSEUDOGONOCOCCAL OPHTHALMIA INFECTION WITH HERELLEA VAGINICOLA , 1968, The Medical journal of Australia.

[404]  A. Lansing,et al.  Five‐Year Follow‐Up Study of Iliofemoral Venous Thrombectomy , 1968, Annals of surgery.

[405]  D. Deykin,et al.  Hepatic removal of activated factor X by the perfused rabbit liver. , 1968, The American journal of physiology.

[406]  D. Negus,et al.  Iliac vein compression.--Its relation to iliofemoral thrombosis and the post-thrombotic syndrome. , 1967, British medical journal.

[407]  S. Gollub Heparin rebound in open heart surgery. , 1967, Surgery, gynecology & obstetrics.

[408]  A. Gornall,et al.  The influence of a heparin-like compound on hypertension, electrolytes and aldosterone in man. , 1966, Canadian Medical Association journal.

[409]  D. Rovner,et al.  Inhibition by heparinoid of aldosterone biosynthesis in man. , 1966, The Journal of clinical endocrinology and metabolism.

[410]  J. Phillips,et al.  A RE-EVALUATION OF ELECTROCARDIOGRAPHS CHANGES ACCOMPANYING ACUTE PULMONARY EMBOLISM , 1966, The American journal of the medical sciences.

[411]  L. Wasserman,et al.  COMPLICATIONS OF POLYCYTHEMIA VERA. , 1966 .

[412]  O. Egeberg Inherited Antithrombin Deficiency Causing Thrombophilia , 1965, Thrombosis and Haemostasis.

[413]  J. Eckenhoff,et al.  Physiological Pharmacology. A Comprehensive Treatise , 1964 .

[414]  P. Olsson,et al.  The elimination from plasma of intravenous heparin. An experimental study on dogs and humans. , 2009, Acta medica Scandinavica.

[415]  E. Bowie,et al.  THROMBOSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS DESPITE CIRCULATING ANTICOAGULANTS. , 1963, The Journal of laboratory and clinical medicine.

[416]  J. Scannell,et al.  A reappraisal of the application of the Trendelenburg operation to massive fatal embolism. Report of a successful pulmonary-artery thrombectomy using a cardiopulmonary bypass. , 1963, The New England journal of medicine.

[417]  J. McLachlin,et al.  An evaluation of clinical signs in the diagnosis of venous thrombosis. , 1962, Archives of surgery.

[418]  S. Shaldon,et al.  Portal hypertension in the myeloproliferative syndrome and the reticuloses. , 1962, The American journal of medicine.

[419]  L. Lee RETICULOENDOTHELIAL CLEARANCE OF CIRCULATING FIBRIN IN THE PATHOGENESIS OF THE GENERALIZED SHWARTZMAN REACTION , 1962, The Journal of experimental medicine.

[420]  H. Sandring,et al.  Aortic arch syndrome with special reference to rheumatoid arteritis. , 2009, Acta medica Scandinavica.

[421]  D. W. Barritt,et al.  Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial. , 1960, Lancet.

[422]  H. Verhagen Local haemorrhage and necrosis of the skin and underlying tissues, during anti-coagulant therapy with dicumarol or dicumacyl. , 2009, Acta medica Scandinavica.

[423]  L. Kleinsasser EFFORT THROMBOSIS OF THE AXILLARY AND SUBCLAVIAN VEINS: An Analysis of Sixteen Personal Cases and Fifty-Six Cases Collected from the Literature , 1949 .

[424]  Conley Cl,et al.  Circulating anticoagulant as a cause of hemorrhagic diathesis in man. , 1948 .

[425]  W. W. Duke The Relation of Blood Platelets to Hemorrhagic Disease: Description of a Method for Determining the Bleeding Time and Coagulation Time and Report of Three Cases of Hemorrhagic Disease Relieved by Transfusion , 1910 .